Type here to filter the list

Monday, Feb 7
10:00 AM – 11:30 AM

Label-Free High-Throughput bioanalytical Technologies

Location: 210C
Wolfgang Reindl, PhD – Boehringer Ingelheim
Catherine Tralau-Stewart, PhD – Takeda Pharmaceuticals
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
10:00 AM – 10:30 AM

Development of Fluorescence and Mass Spectrometry Based Detection Assays for assessment of TMPRSS2 inhibition as Potential Treatment of COVID-19

Location: 210C
John Janiszewski, MS – NIH/NCATS -
Jonathan Shrimp, PhD – NCATS/NIH
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
10:30 AM – 11:00 AM

High throughput covalent fragment screening with MALDI mass spectrometry

Location: 210C
Don D. Nguyen, PhD – Merck
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
11:00 AM – 11:30 AM

Compound Confirmation using Acoustic Ejection-Open Port Interface Mass Spectrometry (AE-OPI-MS) Analysis in Support of High-Throughput Screening Activities

Location: 210C
Jefferson Chin, BSc, MBA – AssayQuant Technologies
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
1:00 PM – 2:30 PM

Label Free Bioanalytical Technologies: Emerging Fields of Application

Location: 210C
Matthias Trost, PhD – Newcastle University
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
1:00 PM – 1:30 PM

MALDI Imaging in drug discovery

Location: 210C
Josephine Bunch
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
1:30 PM – 2:00 PM

Unbiased high-throughput MALDI-TOF MS lipid and metabolite screening assays in primary human cells for drug discovery

Location: 210C
Maria Emilia Duenas, PhD – Newcastle University
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
2:00 PM – 2:30 PM

Acoustic Ejection Mass Spectrometry: A Versatile Technology for Fast Bioanalysis and Fully Automated High-Throughput Screening

Location: 210C
Roman Simon, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
4:00 PM – 5:30 PM

Multi-omic biomarker approaches for Target-Disease Link

Location: 210C
Elnaz Atabakhsh, PhD – Repertoire Immune Medicines
Catherine Tralau-Stewart, PhD – Takeda Pharmaceuticals
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
4:00 PM – 4:30 PM

Coordinated automation to support biomarker discovery using machine learning

Location: 210C
Kevin M. Elias, MD – Brigham and Women's Hospital
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
4:30 PM – 5:00 PM

Enabling the Field: A Strategic Perspective on Molecular Insight

Location: 210C
Bradford Casey, PhD – The Michael J Fox Foundation
Advances in Bioanalytics and Biomarkers
Monday, Feb 7
5:00 PM – 5:30 PM

Multi-Omics analysis mapping fibrotic changes in Bleomycin-induced pulmonary fibrosis in young and old mice

Location: 210C
Daniel Veyel, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
Advances in Bioanalytics and Biomarkers
Tuesday, Feb 8
10:00 AM – 11:30 AM

Target Discovery and Mechanism Deconvolution in Drug Discovery

Location: 210C
Tom Bretschneider, Dr – Boehringer Ingelheim
Yohann Potier, PhD – Tessera Therapeutics
Advances in Bioanalytics and Biomarkers
Tuesday, Feb 8
10:00 AM – 10:30 AM

Defining The Pharmacometabodynamics of Gefitinib after Intravenous Administration to the Mouse by UHPLC/MS and UPLC-IM-MS Study

Location: 210C
Robert Plumb – Waters Corporation - Milford, MA
Advances in Bioanalytics and Biomarkers
Tuesday, Feb 8
10:30 AM – 11:00 AM

Target deconvolution using compressed cellular thermal shift assay (cCETSA) influences key project decisions

Location: 210C
Aarti Kawatkar, APS – AstraZeneca
Advances in Bioanalytics and Biomarkers
Tuesday, Feb 8
11:00 AM – 11:30 AM

Metabolomics and Lipidomics Technologies for Target Discovery and Mechanism Deconvolution.

Location: 210C
Martin Giera, PhD – Leiden University Medical Center
Advances in Bioanalytics and Biomarkers
Tuesday, Feb 8
2:00 PM – 2:30 PM

IR-MALDESI-MS: A New Platform for High Throughput Label-Free Analysis

Location: Grand Ballroom
Nathaniel Elsen, PhD – Abbvie
Advances in Bioanalytics and Biomarkers
Innovation Award

Sponsored By: HighRes Bio